These findings indicate that the loss of MTOR in the lung endothelium is a critical component of ALI progression and severity, and EC expression of MTOR via our gene transfer approach to replenish this loss could be an effective approach to control ALI. The gene discussed is MTOR; the disease is acute respiratory distress syndrome.